Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8027679rdf:typepubmed:Citationlld:pubmed
pubmed-article:8027679lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8027679lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:8027679lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:8027679lifeskim:mentionsumls-concept:C0033416lld:lifeskim
pubmed-article:8027679lifeskim:mentionsumls-concept:C0376152lld:lifeskim
pubmed-article:8027679lifeskim:mentionsumls-concept:C0683278lld:lifeskim
pubmed-article:8027679pubmed:issue1lld:pubmed
pubmed-article:8027679pubmed:dateCreated1994-8-9lld:pubmed
pubmed-article:8027679pubmed:abstractTextViscosity values of marrow cells from patients suffering from acute promyelocytic leukemia (acute myeloid leukemia of type 3) have been determined before and during a treatment with all-trans retinoïc acid (active metabolite of the vitamin A, inducing cell differentiation and maturation). Evaluated from aspiration tests into a glass micropipette, the marrow cell viscosity has been compared to that of normal neutrophils. Results seem to point out that the induced hyperleucocytosis is favoured by both a low standard deviation of pathological cell viscosity and a cell viscosity value close to that of normal neutrophils. The systematic study of cell viscosity could therefore help the clinicians to individualize the treatment.lld:pubmed
pubmed-article:8027679pubmed:languagefrelld:pubmed
pubmed-article:8027679pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8027679pubmed:citationSubsetIMlld:pubmed
pubmed-article:8027679pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8027679pubmed:statusMEDLINElld:pubmed
pubmed-article:8027679pubmed:issn0398-0499lld:pubmed
pubmed-article:8027679pubmed:authorpubmed-author:LacombeCClld:pubmed
pubmed-article:8027679pubmed:authorpubmed-author:BuchererCClld:pubmed
pubmed-article:8027679pubmed:authorpubmed-author:GeigerSSlld:pubmed
pubmed-article:8027679pubmed:authorpubmed-author:DombretHHlld:pubmed
pubmed-article:8027679pubmed:authorpubmed-author:LelièvreJ CJClld:pubmed
pubmed-article:8027679pubmed:issnTypePrintlld:pubmed
pubmed-article:8027679pubmed:volume19lld:pubmed
pubmed-article:8027679pubmed:ownerNLMlld:pubmed
pubmed-article:8027679pubmed:authorsCompleteYlld:pubmed
pubmed-article:8027679pubmed:pagination32-4lld:pubmed
pubmed-article:8027679pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8027679pubmed:meshHeadingpubmed-meshheading:8027679-...lld:pubmed
pubmed-article:8027679pubmed:meshHeadingpubmed-meshheading:8027679-...lld:pubmed
pubmed-article:8027679pubmed:meshHeadingpubmed-meshheading:8027679-...lld:pubmed
pubmed-article:8027679pubmed:meshHeadingpubmed-meshheading:8027679-...lld:pubmed
pubmed-article:8027679pubmed:meshHeadingpubmed-meshheading:8027679-...lld:pubmed
pubmed-article:8027679pubmed:meshHeadingpubmed-meshheading:8027679-...lld:pubmed
pubmed-article:8027679pubmed:meshHeadingpubmed-meshheading:8027679-...lld:pubmed
pubmed-article:8027679pubmed:year1994lld:pubmed
pubmed-article:8027679pubmed:articleTitle[Microrheology of marrow promyelocytes from patients suffering from acute myeloblastic leukemia type 3].lld:pubmed
pubmed-article:8027679pubmed:affiliationUnité de Biorhéologie, Université Paris VI.lld:pubmed
pubmed-article:8027679pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8027679pubmed:publicationTypeEnglish Abstractlld:pubmed